• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 10
  3. Author

Online ISSN: 2515-8260

Volume7, Issue10

CAR-T CELL THERAPY: A REVOLUTIONARY CANCER TREATMENT

    Svetlana Guthrie, Janek Belekov, Sabirakhan Mamatova, Lazokatkhan Dzhumaeva

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 10, Pages 4203-4210

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Cancer is one of the world's leading causes of mortality. A number of conventional cytotoxic approaches for neoplastic diseases have been developed over the years. However, due to their limited effectiveness due to the heterogeneity of cancer cells, there is a constant search for therapeutic approaches with improved outcomes, such as immunotherapy, which utilizes and enhances the patient's immune system's normal capacity.Recently,Adoptive T cell immunotherapy has sparked a lot of interest in cancer treatment. Chimeric antigen T cell (CAR T) treatment has emerged in recent years as an advantageous therapy for treating cancer. CAR-T cell therapy is thought to be an effective treatment for relapsed or refractory tumors. Though the initially approved CAR-T anti-CD19 therapy produced impressive results, retrogressions, including high relapse rates and resistance, led to the need for detection of engineered cells more therapeutically efficient. Significant efficacy and persistence improvements in the design and manufacture of CAR-T cells have been achieved.
 
KEYWORD :- CAR-T cell therapy,function, side effects, CRS, Neurotoxicity, cellular structure, efficacy, safety, failure.
Keywords:
  • PDF (205 K)
  • XML
(2021). CAR-T CELL THERAPY: A REVOLUTIONARY CANCER TREATMENT. European Journal of Molecular & Clinical Medicine, 7(10), 4203-4210.
Svetlana Guthrie, Janek Belekov, Sabirakhan Mamatova, Lazokatkhan Dzhumaeva. "CAR-T CELL THERAPY: A REVOLUTIONARY CANCER TREATMENT". European Journal of Molecular & Clinical Medicine, 7, 10, 2021, 4203-4210.
(2021). 'CAR-T CELL THERAPY: A REVOLUTIONARY CANCER TREATMENT', European Journal of Molecular & Clinical Medicine, 7(10), pp. 4203-4210.
CAR-T CELL THERAPY: A REVOLUTIONARY CANCER TREATMENT. European Journal of Molecular & Clinical Medicine, 2021; 7(10): 4203-4210.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 277
  • PDF Download: 175
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus